New methods of analysing cost effectiveness

British Medical Journal

Volumn 335, Issue 7621, 2007, Pages 622-623

  Briggs, Andrew H ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; INFECTION PREVENTION; INFORMATION PROCESSING; MEDICAL AUDIT; MEDICAL RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; VACCINATION;

BIOMEDICAL TECHNOLOGY; COST-BENEFIT ANALYSIS; GREAT BRITAIN; STATE MEDICINE;

EID: 35148858904     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39332.587581.BE     Document Type: Editorial

References (6)

1. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term "cost effective" in medicine. N Engl J Med 1986;314:253-6.
2. Ades AE, Cliffe S. Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty. Med Decis Making 2002;22:359-71.
3. Claxton K, Sculpher MJ, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002;360:711-5.
4. Colbourn T, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ 2007 doi: 10.1136/bmj.39325.681806.AD.
5. Colbourn TE, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analysis. Health Technol Assess 2007;11(29).
6. Cooksey D. A review of UK health research funding. London: Stationery Office, 2006.